Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common stock ("Common Shares")
-
Shares outstanding
-
212,883,456
-
Total 13F shares
-
21,841,690
-
Share change
-
+1,414,472
-
Total reported value
-
$147,387,866
-
Put/Call ratio
-
36%
-
Price per share
-
$6.75
-
Number of holders
-
65
-
Value change
-
+$9,617,897
-
Number of buys
-
36
-
Number of sells
-
16
Institutional Holders of OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) as of Q2 2018
As of 30 Jun 2018 OCULAR THERAPEUTIX, INC - Common stock ("Common Shares") (OCUL) had 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 21,841,690 shares of stock of the company.
Largest 10 holders included FMR LLC, SUMMER ROAD LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, SV Health Investors, LLC, Opaleye Management Inc., and DELTEC ASSET MANAGEMENT LLC.
This table shows 65 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.